201 related articles for article (PubMed ID: 9717051)
1. Growth factors and vascular smooth muscle cell growth responses.
Delafontaine P
Eur Heart J; 1998 Jul; 19 Suppl G():G18-22. PubMed ID: 9717051
[TBL] [Abstract][Full Text] [Related]
2. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis.
Rudijanto A
Acta Med Indones; 2007; 39(2):86-93. PubMed ID: 17933075
[TBL] [Abstract][Full Text] [Related]
3. Effects of peptide vasoconstrictors on vessel structure.
Hahn AW; Resink TJ; Mackie E; Scott-Burden T; Bühler FR
Am J Med; 1993 Apr; 94(4A):13S-19S. PubMed ID: 8488851
[TBL] [Abstract][Full Text] [Related]
4. [Pathological mechanisms of restenosis after angioplasty. Cell and molecular biology findings--possible new therapeutic approaches].
Bauriedel G
Fortschr Med; 1994 Aug; 112(24):322-3. PubMed ID: 7959499
[No Abstract] [Full Text] [Related]
5. The role of secondary growth factor production in thrombin-induced proliferation of vascular smooth muscle cells.
Stouffer GA; Runge MS
Semin Thromb Hemost; 1998; 24(2):145-50. PubMed ID: 9579635
[TBL] [Abstract][Full Text] [Related]
6. Regulation of smooth muscle cell proliferation and its possible role in preventing restenosis post-angioplasty.
Nikol S; Höfling B
Wien Klin Wochenschr; 1995; 107(13):379-89. PubMed ID: 7638968
[TBL] [Abstract][Full Text] [Related]
7. Synergistic stimulation of airway smooth muscle cell mitogenesis.
Ediger TL; Toews ML
J Pharmacol Exp Ther; 2000 Sep; 294(3):1076-82. PubMed ID: 10945862
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle.
Wang CH; Li SH; Weisel RD; Fedak PW; Dumont AS; Szmitko P; Li RK; Mickle DA; Verma S
Circulation; 2003 Apr; 107(13):1783-90. PubMed ID: 12665485
[TBL] [Abstract][Full Text] [Related]
9. Cytokines and growth factors involved in apoptosis and proliferation of vascular smooth muscle cells.
Rakesh K; Agrawal DK
Int Immunopharmacol; 2005 Sep; 5(10):1487-506. PubMed ID: 16023601
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells.
Hu ZW; Kerb R; Shi XY; Wei-Lavery T; Hoffman BB
J Pharmacol Exp Ther; 2002 Nov; 303(2):563-73. PubMed ID: 12388637
[TBL] [Abstract][Full Text] [Related]
11. [Increased expression of growth factors following angioplasty. Restenosis by stimulation of vascular smooth muscle cells].
Bauriedel G
Fortschr Med; 1992 Apr; 110(11):196. PubMed ID: 1601359
[No Abstract] [Full Text] [Related]
12. Integrin-associated protein binding domain of thrombospondin-1 enhances insulin-like growth factor-I receptor signaling in vascular smooth muscle cells.
Maile LA; Clemmons DR
Circ Res; 2003 Nov; 93(10):925-31. PubMed ID: 14563713
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II as a pro-inflammatory mediator.
Phillips MI; Kagiyama S
Curr Opin Investig Drugs; 2002 Apr; 3(4):569-77. PubMed ID: 12090726
[TBL] [Abstract][Full Text] [Related]
14. Estrogen regulates insulin-like growth factor 1, platelet-derived growth factor A and B, and their receptors in the vascular wall.
Savolainen-Peltonen H; Loubtchenkov M; Petrov L; Delafontaine P; Häyry P
Transplantation; 2004 Jan; 77(1):35-42. PubMed ID: 14724432
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions.
Moralez AM; Maile LA; Clarke J; Busby WH; Clemmons DR
J Cell Physiol; 2005 May; 203(2):328-34. PubMed ID: 15700281
[TBL] [Abstract][Full Text] [Related]
16. Peptide growth factors and signal transduction.
Sidawy AN; Mitchell ME; Neville RF
Semin Vasc Surg; 1998 Sep; 11(3):149-55. PubMed ID: 9763115
[TBL] [Abstract][Full Text] [Related]
17. [Growth factors and cytokines in the pathogenesis of cardiovascular diseases].
Habenicht AJ; Janssen-Timmen U; Salbach PB; Blattner C; Ziegler R
Verh Dtsch Ges Inn Med; 1991; 97():467-9. PubMed ID: 1808929
[No Abstract] [Full Text] [Related]
18. [Roles of cytokines and growth factors in atherogenesis].
Kawakami M; Kuroki M
Nihon Rinsho; 1993 Aug; 51(8):2010-5. PubMed ID: 8411665
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive peptides and growth factors in the pathophysiology of hypertension.
Scott-Burden T; Hahn AW; Bühler FR; Resink TJ
J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S55-64. PubMed ID: 1380620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
